Development of an infusible-grade solution for non-cryopreserved hematopoietic cell storage

Cytotherapy. 1999;1(2):123-33. doi: 10.1080/0032472031000141250.

Abstract

Background: Various tissue culture medium formulations currently are used to transport, store and process stem and progenitor cells for transplantation, although these solutions are not manufactured for clinical use.

Methods: We have developed an infusible-grade solution, STM-Sav, for short-term liquid cell storage and tested its ability to maintain viable functional hematopoietic cells, compared with commonly-used tissue culture solutions. G-CSF-stimulated normal-donor PBPC were stored in alpha-MEM, IMDM, RPMI-1640, AIM 5, X-VIVO 10, PlasmaLyte A and STM-Sav, in gas-permeable Cryocyte bags, at ambient temperature and 4 degrees C. The percentage of viable cells, percent recovery of viable mononuclear cells (MNC), percentage of CD34+ cells, CFU-GM frequency and solution pH were determined for each solution, at time points ranging from 0 to 72 h.

Results: Cells were slightly better maintained at 4 degrees C than at ambient temperature. No solution was superior to any other overall, although PlasmaLyte A was significantly inferior to all other solutions at preserving viable MNC. STM-Sav consistently maintained viable, functional cells as well as, or better than in-vitro-use-only culture media, or PlasmaLyte A.

Discussion: Cells could be stored in STM-Sav for at least 24 h at 4 degrees C or ambient temperature, with recovery of approximately 90% of initial viable MNC, unchanged percentage CD34+ cells and stable solution pH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD34 / analysis
  • Cell Proliferation
  • Cell Survival / drug effects
  • Cold Temperature
  • Colony-Forming Units Assay
  • Culture Media / pharmacology
  • Electrolytes / pharmacology
  • Granulocyte Colony-Stimulating Factor / pharmacology
  • Granulocyte-Macrophage Progenitor Cells / drug effects
  • Hematopoietic Stem Cell Transplantation / methods*
  • Hematopoietic Stem Cells / drug effects*
  • Hematopoietic Stem Cells / immunology
  • Humans
  • Hydrogen-Ion Concentration
  • Preservation, Biological / methods*
  • Protective Agents / pharmacology*
  • Refrigeration
  • Time Factors

Substances

  • Antigens, CD34
  • Culture Media
  • Electrolytes
  • Protective Agents
  • Granulocyte Colony-Stimulating Factor
  • Plasmalyte A